In the UK, marijuana as you may know is totally illegal which is a shame and we should be taking notes from our American counterparts in relations to these laws, but we do have some totally exciting news that we are happy to report back to your guys!
For the first time ever the National Health Service (NHS) in the UK are going to be trialling CBD (cannabidiol) medicine which as we know, has been a successful method of treatment for users in other countries.
The medicine comes in the form of a vaporizer, named the Medipen and according to the Independent; the Medipen Company has been consulting with a group of production and regulatory support pharmacists from the NHS for the past few months, who have been testing their proprietary cannabis oil formulation.
A public report detailing the testing process is said to follow this report and this is a big first step for the medical cannabis industry in the UK and MediPen have confirmed
‘As the first consumer cannabis product to be tested by the NHS, we are confident that this will go a long way towards creating a properly regulated cannabis market in the UK and are extremely excited to see what the future holds. – MediPen’
They also went on to say that they are aiming to try and squash any negativity surrounding cannabis –
‘The company has said the “negative connotations” surrounding the drug are “having a detrimental impact on millions of lives across the UK”.‘
The coconut oil based product does not contain any THC, the compound of cannabis that essentially gets you high, it is legal and is available for sale in the UK, but unfortunately as these trials are still in the early stages, there are no plans as of yet to make the Medipen or any similar medical CBD vaporiser products available to UK patients on the NHS.
The ‘MediPen’ is designed to help people cope with ailments and illnesses and to support pain relief from those suffering from conditions including aids, depression, cancer and arthritis.
The company told The Independent it has been consulting with a group of production and regulatory support pharmacists from the NHS for the past few months, who have been testing their proprietary cannabis oil formulation.
“Over the past year the MediPen has quickly become without a doubt one of the most highly-rated CBD products in the world,” said managing director Jordan Owen. “We’ve recently been working very closely with a team of NHS production and regulatory support pharmacists who’ve been able to meticulously analyse our proprietary formulation for both safety and cannabinoid concentration.
The NHS was unable to comment due to a non-disclosure agreement preventing them from sharing any client information, with the exemption of official government bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA). It did however point out that cannabidiol is present in the authorised multiple sclerosis spray product Sativex, which we have blogged about before.
Vaping has become a ‘thing’ over the past few years and is one of the ‘safest’ ways to consume what could potentially be toxic as a vaporiser heats the plant material at a moderate temperature, causing the active cannabinoids to evaporate into an aerosol that contains far fewer harmful components.
The full report that is to be released by the NHS will more than likely detail how they plan to introduce this medicine and make it available for those who are currently suffering from chronic illness.
Please Note: This content is for informational and educational use only. The Attitude Seed bank sells all seeds strictly for souvenir purposes only or for storage in case the laws in the UK may change and for the conservation of cannabis seeds. We do not condone or encourage the germination of these cannabis seeds and we will refuse a sale to anyone who leads us believe they will use these for anything other than souvenir purposes. Seeds sold by The Attitude Seedbank may not be germinated in countries not legal to do so.
WARNING: IT IS A CRIMINAL OFFENSE TO GERMINATE CANNABIS SEEDS IN MOST COUNTRIES.